---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-257733"
form_type: "8-K"
ticker: "JBIO"
cik: "0001798749"
company_name: "Jade Biosciences, Inc."
filed_at: "2026-06-04T21:09:05+00:00"
generated_at: "2026-06-04T21:20:14.234967+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Jade Biosciences prices $150M public offering of 10M shares at $15/share

## Summary
- Priced public offering of 10,000,000 shares of common stock at $15.00 per share for gross proceeds of $150.0M.
- Net proceeds expected ~$140.3M (~$161.5M if underwriters’ 30-day option for 1.5M additional shares is exercised).
- Intends use net proceeds for clinical trials, preclinical studies, manufacturing, R&D, capex, working capital, and general corporate purposes.
- Jefferies, TD Cowen, UBS Investment Bank acting as joint book-running managers; offering expected to close June 5, 2026.

## SEC filing metadata
- accession: 0001193125-26-257733
- form_type: 8-K
- ticker: JBIO
- cik: 0001798749
- company_name: Jade Biosciences, Inc.
- filed_at: 2026-06-04T21:09:05+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1798749/000119312526257733/0001193125-26-257733-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1798749/000119312526257733/d103726d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-257733
- JSON: https://secwatch.observer/filing/0001193125-26-257733.json
- Plain text: https://secwatch.observer/filing/0001193125-26-257733.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.